Clinical trials
Gallbladder Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 10 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Unknown status | 18 |
| Recruiting | 11 |
| Not yet recruiting | 4 |
| Withdrawn | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ajou University School of Medicine | 6 |
| Assiut University | 2 |
| Ataturk University | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Sisli Hamidiye Etfal Training and Research Hospital | 2 |
| Tecnologico de Monterrey | 2 |
| Umeå University | 2 |
| University of Calgary | 2 |
| Zagazig University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Diseases | 89 |
| Gallstones | 12 |
| Cholecystitis, Acute | 11 |
| Cholelithiasis | 10 |
| Pancreatic Diseases | 10 |
| Cholecystitis | 9 |
| Biliary Tract Diseases | 7 |
| Choledocholithiasis | 7 |
| Bile Duct Diseases | 4 |
| Cholecystolithiasis | 4 |
Trials
Showing 76 to 89 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.